USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Noster Inc.

USPTO PatentsView assignee record - 9 granted patents across 13 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

8.2

Avg claims per patent

5-year filing velocity

The verdict

Noster holds 9 US patents across 13 technology areas, rank #29,552 of 50,000 tracked assignees.

#29,552
of 50,000 US assignees by volume: Top 73%
by Innovation Score (28.3/100): 8.2
avg claims per patent

Portfolio overview

Noster Inc. has been granted 9 US utility patents between 2020 and 2025, placing Noster Inc. at rank #29,552 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.2 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Noster Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Noster sits between NKT Cables Group A/s (9 patents, rank #29,548) and Novelis Koblenz Gmbh (9 patents, rank #29,556) - the closest US assignees by grant volume. The composite Innovation Score of 28.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Noster Inc.'s 8.2 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Noster Inc. against peers pursuing similar technology classes.

NKT Cables Group…

9
Nobelpharma

9
Norbrook Laborato…

9
Norotos

9
NOV Canada ULC

9
Novartis Tiergesu…

9
Novation IQ

9
Novelis Koblenz

9
Noster ◀

9

What this shows Noster holds 9 patents at rank #29,552, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Noster

By rank, the assignees closest to #29,552 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Noster's primary technology class.

Noster's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

28 Top 73% higher than 27% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Noster Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	11.1%
2021	4	44.4%
2022	1	11.1%
2023	1	11.1%
2025	2	22.2%

Which technologies does Noster Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 6

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 6

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 4

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 4

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 4

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 3

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 3

A23K - FODDER 2

C12R - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS 2

C07K - PEPTIDES 2

A61Q - SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS 1

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 1

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1

Top 13 of 13 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Simple

Where it ranks

Overall rank by patents

#29,552

Across all tracked assignees

Innovation Score

28.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Noster Inc. hold?

Noster Inc. holds 9 US granted patents filed between 2020 and 2025, spanning 13 technology areas.

What is Noster Inc.'s Innovation Score?

Noster Inc. has an Innovation Score of 28.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Noster Inc. focus on?

Noster Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 6 patents. The company has filed patents in 13 CPC subclasses total.

Is Noster Inc.'s patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Noster Inc..

What does claim depth mean for Noster Inc.'s patents?

Noster Inc.'s patents average 8.2 claims each. This is relatively simple claim structure, typical for focused inventions.

How is the Noster Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Noster's 9 grants land it in the top 73% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Noster ranks #29,552 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.